Literature DB >> 28403467

Development of Social and Demographic Differences in Maternal Smoking Between 1999 and 2014 in Norway.

Liv Grøtvedt1, Liv Grimstvedt Kvalvik2, Else-Karin Grøholt1, Rupali Akerkar3, Grace M Egeland2,3.   

Abstract

INTRODUCTION: The Medical Birth Registry of Norway provides national coverage of all births in Norway. In this study trends of smoking at the beginning of pregnancy and the variation of these trends across different sociodemographic groups are analyzed. This knowledge is important for planning interventions both in the general population and specifically among pregnant women.
METHODS: All births registered in Medical Birth Registry of Norway 1999-2014 with information on mothers' smoking status were included in the overall analyses of the smoking trends (806 298). Records from 210 268 births in two time periods 1999-2000 and 2013-2014 were selected, and for the multivariate analyses we used general linear models to provide adjusted risk ratios.
RESULTS: The prevalence of maternal smoking at the beginning of pregnancy decreased from 25% to 8% over the 15-year period. Mothers with low, medium, and high education, respectively, had a 46% (RR 0.54, CI 0.52-0.55), 62% (RR 0.38, CI 0.37-0.40), and 80% (RR 0.20, CI 0.19-0.22) reduction in maternal smoking between the two time periods. Similarly, the decline in smoking was greater for mothers who were married or living together (64%; RR 0.36, CI 0.35-0.37) than for single mothers (39%; RR 0.61, CI 0.58-0.64). Immigrants had a lower smoking prevalence than Norwegians in the entire period 1999-2014.
CONCLUSION: The prevalence of smoking during pregnancy in Norway decreased in all population groups, but the relative differences between the educational groups increased from 1999-2000 to 2013-2014. This is a public health concern and a strong contributor to health disparities. IMPLICATIONS: Women with low and medium education level and single mothers had the highest smoking prevalence and the lowest decline over the two time periods. These groups constitute 45% of our study population, the relatively high maternal smoking in these groups continues to be of public health concern for maternal and child health.
© The Author 2017. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2017        PMID: 28403467     DOI: 10.1093/ntr/ntw313

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  12 in total

1.  Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Authors:  Baoyun Xia; Benjamin C Blount; Tonya Guillot; Christina Brosius; Yao Li; Dana M Van Bemmel; Heather L Kimmel; Cindy M Chang; Nicolette Borek; Kathryn C Edwards; Charlie Lawrence; Andrew Hyland; Maciej L Goniewicz; Brittany N Pine; Yang Xia; John T Bernert; B Rey De Castro; John Lee; Justin L Brown; Stephen Arnstein; Diane Choi; Erin L Wade; Dorothy Hatsukami; Gladys Ervies; Angel Cobos; Keegan Nicodemus; Dana Freeman; Stephen S Hecht; Kevin Conway; Lanqing Wang
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

2.  Association between pregravid physical activity and family history of stroke and risk of stillbirth: population-based cohort study.

Authors:  Grace M Egeland; Grethe S Tell; Øyvind Næss; Jannicke Igland; Kari Klungsøyr
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

3.  Placental weight and birthweight: the relations with number of daily cigarettes and smoking cessation in pregnancy. A population study.

Authors:  Sandra Larsen; Camilla Haavaldsen; Elisabeth Krefting Bjelland; Johanne Dypvik; Anne Marie Jukic; Anne Eskild
Journal:  Int J Epidemiol       Date:  2018-08-01       Impact factor: 7.196

4.  Prevalence and predictors of maternal smoking prior to and during pregnancy in a regional Danish population: a cross-sectional study.

Authors:  Mie Gaarskjaer de Wolff; Mette Grønbæk Backhausen; Mette Langeland Iversen; Jane Marie Bendix; Ane Lilleøre Rom; Hanne Kristine Hegaard
Journal:  Reprod Health       Date:  2019-06-14       Impact factor: 3.223

5.  Stopping when knowing: use of snus and nicotine during pregnancy in Scandinavia.

Authors:  Ina Kreyberg; Karen E S Bains; Kai-H Carlsen; Berit Granum; Hrefna K Gudmundsdóttir; Guttorm Haugen; Gunilla Hedlin; Katarina Hilde; Christine M Jonassen; Live S Nordhagen; Björn Nordlund; Katrine D Sjøborg; Håvard O Skjerven; Anne C Staff; Cilla Söderhäll; Riyas M Vettukatil; Karin C Lødrup Carlsen
Journal:  ERJ Open Res       Date:  2019-04-08

6.  Trends in maternal use of snus and smoking tobacco in pregnancy. A register study in southern Norway.

Authors:  Ellen Rygh; Frode Gallefoss; Liv Grøtvedt
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-16       Impact factor: 3.007

7.  Maternal complications in pregnancy and childbirth for women with epilepsy: Time trends in a nationwide cohort.

Authors:  Kim Christian Danielsson; Nils Erik Gilhus; Ingrid Borthen; Rolv Terje Lie; Nils-Halvdan Morken
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

8.  Evaluation of incomplete maternal smoking data using machine learning algorithms: a study from the Medical Birth Registry of Norway.

Authors:  Liv Grøtvedt; Grace M Egeland; Liv Grimstvedt Kvalvik; Christian Madsen
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-23       Impact factor: 3.007

9.  Smoking during pregnancy. Results of the cross-sectional KiGGS Wave 2 study and trends.

Authors:  Benjamin Kuntz; Johannes Zeiher; Anne Starker; Franziska Prütz; Thomas Lampert
Journal:  J Health Monit       Date:  2018-03-15

10.  The importance of socioeconomic position in smoking, cessation and environmental tobacco smoke exposure during pregnancy.

Authors:  Joana Madureira; Alexandra Camelo; Ana Inês Silva; Ana Teresa Reis; Filipa Esteves; Ana Isabel Ribeiro; João Paulo Teixeira; Carla Costa
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.